Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Zentalis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HAUSMAN DIANA
Zentalis Pharmaceuticals | 10-Q: Quarterly report
Zentalis Pharmaceuticals | 8-K: Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
Zentalis Pharmaceuticals | DEFA14A: Others
Zentalis Pharmaceuticals | DEF 14A: Definitive information statements
Zentalis Pharmaceuticals | ARS: Annual Report to Security Holders
Zentalis Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Vultaggio Vincent
Zentalis Pharmaceuticals | 8-K: Current report
Zentalis Pharmaceuticals | 8-K: Current report
Zentalis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Zentalis Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Zentalis Pharmaceuticals | 10-K: Annual report
Zentalis Pharmaceuticals | 8-K: Current report
Zentalis Pharmaceuticals | 8-K: Current report
Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(5.3%),Citadel Advisors LLC(5.1%), etc.
Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.56%)
Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(0%),Avidity Partners Management (GP) LLC(0%), etc.
Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data